IND-Enabling Safety Studies for ART5803, a Clinical-Stage Therapeutic One-Armed Antibody to Treat Anti-NMDA Receptor Encephalitis (S7.004)
To assess the safety profile of ART5803, a therapeutic one-armed antibody to block the pathogenicity of anti-NMDA receptor (NMDAR) autoantibodies (autoAbs) in patients with anti-NMDAR encephalitis (ANRE).
Authors
- Mathew Mitchell
- Roghiye Kazimi
- Amir S. Razai (ORCID: https://orcid.org/0000-0002-7172-0713)
- Martin R. Jefson
- Shanni Yamaki
- Mitsuyuki Matsumoto (ORCID: https://orcid.org/0000-0002-1172-2354)
- Peter Flynn (ORCID: https://orcid.org/0009-0008-7704-3718)
- Vallari R. Eastman
- Scott J. Snipas (ORCID: https://orcid.org/0000-0002-4239-6862)
- Jay B. Lichter
- Mari Maurer
Institutions
- Elusys Therapeutics (United States) (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208619
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00